Throughout our journey developing PRESS, we met with relevant stakeholders from different departments. Every meeting really had its own story. We gained as much as we could from the experts we met along the way. This helped us refine our plans and ideas to align with the latest rules and guidelines. We had to make sure that PRESS complies with all regulations and recent updates in all aspects, starting from its scientific and technological foundations and going all the way to the strategic plan for getting the final product into the market.
Our stakeholders are categorized into six main groups: Healthcare providers,Asthma Patients, Lab support, Regulatory bodies, Manufacturing and Marketing Partnerships. The timeline of our project’s journey included a number of meetings and visits represented which were efforts made to ensure our human-centric approach.
The Integrated Human Practices page demonstrates detailed information about all the stakeholder interactions seen in an eight stage development process with tools used to clarify our idea.
In the timeline of each stage in integrated human practice, a colored bookmark is used to indicate the category each stakeholder belongs to. As a final step, we organized all stakeholders into six distinct categories based on their specific roles:
1- Asthma Patients & Caregivers
2- Healthcare Providers & Emergency Department Administrators
3- Ethics, Safety & Legal Professionals
4- Research & Clinical Trial Experts
5- Industry & Economy
6- The Public & Society
During our brainstorming sessions at AFCM headquarters, team members were tossing ideas about what topic we would adopt this year.....
Al-Abbasya Chest Hospital, is a local chest hospital in Cairo, Egypt. This hospital is well known for its wide range of facilities and profound chest professors. As well, it holds a large number of asthmatic patients who were able to tell us their stories and experiences.
During our educational visit to Abassya Hospital, Cairo, Egypt, we had the opportunity to meet with Dr. Sameh Ahmed, the chief of the chest department.
The Pulmo-Port conference was the first of its kind in Port Said, Egypt. It witnessed the gathering of a large number of chest and allergy doctors from various entities. Held under the supervision of the General Authority for Health Care and the Doctors Syndicate, the event included participation from many associations, such as the Egyptian Society of Allergy and Immunology.
Prof. Ahmed Bashir, the main president of the Pulmo-event conference and a well-known professor of chest diseases at Al-Azhar University.
Dr. Mohamed Hussein is an Associate Research Professor at City of Hope, CA, USA / Professor at Zigzag University, Egypt. A profound expert in the field of genetic engineering.
Dr. Ahmed Atef, the CEO of Egyptian genetic engineering society and a biomedical professor with expertise in molecular biology, cloning, and genetic assembly. He provided us with valuable practical support in plasmid purification, transformation, and DNA assembly methods.
Dr. Raghda, an expert in molecular biology and bioinformatics. She is well known with her expertise in both wet lab experimentation and dry lab validation.
Dr.Hazman is an Associate Professor at Agricultural Genetic Engineering Research Institute (AGERI) and a Part-time associate professor at Nile University, Egypt. Dr Hazman is a profound expert at wet lab, which is one of the most needed scientific fields’ worldwide involving structure and function validations such as Polymerase Chain Reaction (PCR), isolation techniques, and molecular cloning.
World Asthma Day is an annual event organized by the global initiative for asthma to address critical challenges and raise awareness about asthma. This year, the event included expert speakers’ from outside Egypt, also well-known Egyptian doctors. We had the chance to be a part of the 33rd annual asthma conference & 26th Egyptian celebration of world asthma day.
Dr. Souzan Fouad, Medical Representative in European Pharmaceuticals Company, one of the leading companies in the field of medications manufacturing.
Dr. Tarek Salim, is a medical representative of Eva Pharm Company who has over 20 years of expertise in the inhaler industry. With his experience in patient care and drug efficacy testing, he offers us invaluable insights towards PRESS design.
At this stage we contacted Dr. Wagida Anwar, a professor at the department of community, environmental and occupational medicine and the head of the IRB committee of AFCM. Then, at a wider scope, we had a meeting with Mr. Yahia Badawy, an Egyptian legal counsel from AXA health insurance. Finally, Mr. REJEESH, who is a senior consultant at TopCertifier, which is a company that offers US FDA Certification Consultation in Egypt.
Zagazig University Hospitals is a group of specialized hospitals affiliated with the Faculty of Medicine, Zagazig University. These hospitals have proven their excellence throughout Egypt in terms of patient care and the level of healthcare services provided.
Dr.Mohamed anany is the Chief of the Chest Department at Zagazig Hospital, highly experienced chest and respiratory diseases specialist.
Dr. Ahmed Mansour one of the pioneers in the field of biosafety at EPICO
Dr. Asmaa Mohamed is a psychiatric doctor specialized in the psychological impact of chronic diseases. Through her career, she has extensive experience supporting patients with burnout and emotional strain, including those managing asthma.
Aiming to achieve a better environment for asthmatic patients, an idea emerged into our minds toward making a guidebook for an asthma friendly city. Therefore, we have contacted expert engineers like Eng. Elsebaey, Eng. Salama and Eng. Mohamed.
Dr. Noha El-Husseiny is the President of the National Council for Women in South Sinai, she encourages women’s participation in social, economic, and political life, and she strives to advance gender equality and inclusivity nationwide.
EIPCO Pharmaceutical Factory is one of the leading factories in Egypt and the Arab region, following the latest global methods and technologies and adhering to the latest guidelines in pharmaceutical manufacturing.
Pharmaconex is one of the leading pharmaceutical conferences in the Middle East and North Africa region. This event serves as a platform for exploring the latest discoveries in the field of pharmaceuticals.
Dr.Mohamed Mahrous, who is currently a Medical Science Liaison for Respiratory and Immunology at AstraZeneca, which is a multinational science-led biopharmaceutical company that invests in research and development of innovative therapies.Mr Mahrous brings his experience from his previous work on medical affairs regarding pediatric and adult Asthma.
From its first spark of inspiration to its first steps in the real world, PRESS has grown into more than a scientific idea. It has become a vision for the future of asthma care. Along this journey, it was tested by science, evolved by experts, guided by ethics,and shaped by community voices. Each step brought PRESS closer to reality from lab to hospitals, from patients' conversations to industry halls, and from local start to global possibilities.
This journey has revealed that the matter is not just about creating new therapies—it is about listening, adapting, and carrying the responsibility of improving lives. PRESS stands now as more than a treatment. It stands as a promise of relief, and hope for millions struggling with asthma. And with every step forward, that promise brings the future of better breathing.
Content will appear here
